MarketWatch8h
Henry Schein Inc. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Exclusive: Activist investor Ananym Capital pushes for changes at Henry Schein, sources say
Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut costs, tackle succession planning and consider selling its medical ...
Seeking Alpha11h
Henry Schein extends gain on report of activist stake, push for board changes
A sale of the medical distribution business could increase Henry Schein's (HSIC) shares by 20%, while EPS could jump by ~35% ...
Business Insider17h
Ananym urges Henry Schein to cut spending, sell unit, Reuters reports
Activist Ananym Capital Management is urging Henry Schein (HSIC) to refresh its board, cut costs, tackle succession planning and consider selling its medical distribution business, Svea Herbst-Bayliss ...